Written by Megan Wood | Tuesday, 02 August 2016
Here are seven things to note:
1. Jeffries analysts expect Warsaw, Ind.-based Zimmer Biomet to continue to grow in the latter half of 2016. The company’s overall revenue growth proved 2.5 percent better than analysts’ estimates.
2. Zimmer Biomet also reported second quarter revenue of $1.93 billion, which exceeded Wall Street analysts’ expectations of $1.9 billion.
3. The company’s continued growth is only elevated by its recent M&A activity. Zimmer Biomet acquired LDR Holding for $1 billion, with a deal set to close in the third quarter.
